Immediate Impact
57 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Aiping Zhou being referenced
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
2020 Standout
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Aiping Zhou | 280 | 442 | 326 | 78 | 932 | |
| Munita Bal | 295 | 451 | 495 | 122 | 1.1k | |
| Byoung Kwan Son | 211 | 268 | 259 | 94 | 977 | |
| Michael Doukas | 287 | 398 | 361 | 64 | 1.1k | |
| Catherine Devine | 338 | 218 | 250 | 53 | 999 | |
| Federica Gaiani | 216 | 271 | 502 | 59 | 1.1k | |
| William W. Shingleton | 248 | 353 | 333 | 59 | 1.0k | |
| Antonio Russo | 236 | 199 | 257 | 63 | 966 | |
| E. Uchida | 136 | 447 | 245 | 56 | 1.1k | |
| Jianwei Zhang | 180 | 258 | 228 | 79 | 869 | |
| Thiruvengadam Muniraj | 281 | 430 | 563 | 76 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...